Maddyness interview “Ignota Labs, solving drug safety issues and bringing new hope to patients”, with cofounder and CEO Sam Windsor
Ignota Labs logo and LinkedIn page on a phone and a laptop
Pharmaphorum article by co-founder and CSO Jordan Lane, “Why drugs fail: the unrelenting challenge of finding a new drug”
Ignota Labs brand background, a soft blue gradient with fine flowing lines
Tech.eu article “Ignota Labs raises $6.9M to rescue failing drugs with AI technology”, with three members of the team
No items found.

Ignota Labs

AI-driven drug rescue

Ignota Labs uses AI to solve drug safety issues and give failed drugs a second chance.

Strategy

Ignota Labs brought on Commplicated to help get them ready to raise a seed round.

Execution

We updated their brand to be investor- and customer-ready, redid the whole website and took over management of their social media. Working with the Ignota team, we also simplified their messaging and differentiated them from other ai drug discovery companies.

Results

Ignota Labs successfully raised their seed round of £5.5M from top Silicon Valley investors, exceeding their initial fundraising target. They have also been featured in Endpoints, Pharmaphorum, and Technology Networks. Commplicated continues to support them on their journey.

Client
Ignota Labs
Country
United Kingdom
Area of business
AI drug discovery
Services
Strategic messaging and positioning
Brand strategy and building
Media relations
LinkedIn strategy and management
"Commplicated has been more than just a comms agency, the team has supported us with all external-facing aspects of the business. They have made connections, polished the founders' image, helped us understand the wider investment market trends and state of affairs, and given us the energy and encouragement to be ambitious and to go out to do what we do best. They are the perfect addition to any team to supercharge your growth."
Sam Windsor
Sam Windsor
CEO
at
Ignota Labs